Can you provide the last earnings date for ELEVANCE HEALTH INC?
ELEVANCE HEALTH INC (ELV) last reported earnings on 1/28/2026.
ELEVANCE HEALTH INC (ELV) Earnings History & Surprises
NYSE:ELV • US0367521038
Current stock price
295.75 USD
+3.68 (+1.26%)
At close:
342.75 USD
+47 (+15.89%)
After Hours:
ELV Earnings overview
Past quarterly earnings results for ELEVANCE HEALTH INC (ELV), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 20, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $10.73
- Revenue Estimate
- 49.148B
Last Reported
Most Recent- Release Date
- Jan 28, 2026
- Period
- Q4 / 2025
- EPS Reported
- $3.33
- EPS Surprise
- 6.46%
- Revenue Surprise
- -2.00%
Beat Rate
Last 8 Quarters 63%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 3.33 | 3.13 | 6.46% | -13.28% | 49.311B | 50.315B | -2.00% | 9.61% |
| Q3 2025 | 6.03 | 4.98 | 21.02% | -27.96% | 50.087B | 49.863B | 0.45% | 12.00% |
| Q2 2025 | 8.84 | 9.04 | -2.26% | -12.65% | 49.421B | 48.717B | 1.45% | 14.34% |
| Q1 2025 | 11.97 | 11.50 | 4.12% | 12.50% | 48.765B | 46.753B | 4.30% | 15.36% |
| Q4 2024 | 3.84 | 3.83 | 0.17% | -31.67% | 44.989B | 45.311B | -0.71% | 5.97% |
| Q3 2024 | 8.37 | 9.76 | -14.20% | -6.90% | 44.719B | 43.8B | 2.10% | 5.27% |
| Q2 2024 | 10.12 | 10.11 | 0.10% | 11.95% | 43.223B | 43.485B | -0.60% | -0.36% |
| Q1 2024 | 10.64 | 10.64 | 0.03% | 12.47% | 42.273B | 43.052B | -1.81% | 0.24% |
| Q4 2023 | 5.62 | 5.70 | -1.40% | 7.46% | 42.454B | 42.466B | -0.03% | 6.32% |
| Q3 2023 | 8.99 | 8.52 | 5.47% | 19.39% | 42.48B | 43.042B | -1.31% | 6.36% |
| Q2 2023 | 9.04 | 8.88 | 1.75% | 12.44% | 43.377B | 41.917B | 3.48% | 12.28% |
| Q1 2023 | 9.46 | 9.35 | 1.13% | 14.67% | 42.172B | 41.24B | 2.26% | 10.70% |
| Q4 2022 | 5.23 | 5.24 | -0.20% | 1.75% | 39.929B | 40.038B | -0.27% | 9.15% |
| Q3 2022 | 7.53 | 7.22 | 4.30% | 10.90% | 39.939B | 39.479B | 1.17% | 11.49% |
| Q2 2022 | 8.04 | 7.82 | 2.84% | 14.37% | 38.632B | 38.51B | 0.32% | 14.12% |
| Q1 2022 | 8.25 | 7.89 | 4.54% | 17.69% | 38.095B | 37.727B | 0.98% | 17.63% |
| Q4 2021 | 5.14 | 5.16 | -0.46% | 102.36% | 36.581B | 36.878B | -0.81% | 15.18% |
| Q3 2021 | 6.79 | 6.43 | 5.53% | 61.67% | 35.822B | 35.652B | 0.48% | 14.90% |
| Q2 2021 | 7.03 | 6.40 | 9.93% | -23.59% | 33.851B | 33.536B | 0.94% | 15.72% |
| Q1 2021 | 7.01 | 6.58 | 6.57% | 8.18% | 32.385B | 33.272B | -2.67% | 9.12% |
| Q4 2020 | 2.54 | 2.55 | -0.21% | - | 31.76B | 31.089B | 2.16% | - |
| Q3 2020 | 4.20 | 4.19 | 0.15% | - | 31.176B | 30.111B | 3.54% | - |
| Q2 2020 | 9.20 | 8.96 | 2.64% | - | 29.253B | 29.542B | -0.98% | - |
| Q1 2020 | 6.48 | 6.54 | -0.94% | - | 29.678B | 28.885B | 2.75% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
7.33%
Max EPS beat (4)
21.02%
Min EPS beat (4)
-2.26%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
1.05%
Max Revenue beat (4)
4.30%
Min Revenue beat (4)
-2.00%
Analysis
In the last 4 quarters, ELV has beaten EPS estimates in 3 out of 4 releases
ELV has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, ELV has beaten the EPS estimates by 7.3% on average.
In the last 4 quarters, ELV has beaten the revenue estimates by 1.1% on average.
Related analysis
ELEVANCE HEALTH INC / ELV Earnings FAQ
Can you provide information on whether ELEVANCE HEALTH INC beat earnings estimates in the last quarter?
ELEVANCE HEALTH INC (ELV) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does ELV stock beat earnings estimates?
In the last 4 quarters, ELEVANCE HEALTH INC (ELV) has beaten EPS estimates in 3 out of 4 releases.